Amiotrófiás laterálszklerózis (ALS): vizsgálatok itt: Görögország
2 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisFelfüggesztveEfficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
- Where
- Athens
- Életkor
- 18 év to 80 év
- People
- 412 worldwide
- Run by
- AB Science
See details and how to joinNCT07174492 · EU 2024-511244-12-01 - 3. fázisTaking peopleEfficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Where
- Athens, Larissa, Rio
- Életkor
- 18 év to 81 év
- People
- 495 worldwide
- Run by
- AB Science
See details and how to joinNCT03127267